CAR-T | CHOP Research Institute
 

CAR-T

Published on
May 11, 2022
In this Q&A, Stephan Grupp, MD, PhD, discusses his experience delivering CAR T-cell therapy to the first pediatric patient, Emily Whitehead.
Published on
Nov 3, 2021
The peptide-centric CAR T cells, or PC-CARS, target cancer drivers in tumor cells previously thought unreachable.

Shifting the paradigm to treat the toughest pediatric cancers with new cell therapies that reprogram a patient's own immune system to kill cancer cells.